Tanjina Kader 34th Lorne Cancer Conference 2022

Abstracts this author is presenting:

• Predictive biomarkers of recurrence may not be useful for deescalating treatment of breast ductal carcinoma in situ due to de novo ipsilateral breast carcinoma development — Welcome Function and Poster Session 1